Form 4 for MREO Mereo BioPharma Group plc
Accepted 2024-06-17 00:00:00 ET · period of report 2024-06-17 · accession 0000950170-24-074248 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-17 | 2024-06-17 | MREO | WYZGA MICHAEL S | Dir | A - Grant | $3.99 | +25.1K | 25.1K | New | +$99.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares representing Ordinary Shares | 2024-06-17 | A | A | 25,050 | $3.99 | 25,050 | D | — | — | (F1) Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. |